Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

First Edition

Research Article August 5 2025
Outcomes of CAR T-cells therapy in High-grade B-cell lymphomas compared to DLBCL: a weighted comparison analysis
Research Article August 5 2025
Treatment and outcomes of progression of disease post-CAR T-cell therapy in mantle cell lymphoma: a multicenter analysis
Letter August 5 2025
Mini-Hyper-CVD plus Venetoclax and Navitoclax for Relapsed/Refractory Acute Lymphoblastic Leukemia
Research Article August 5 2025
Characteristics and outcomes of Kaposi sarcoma herpesvirus (KSHV)-associated inflammatory cytokine syndrome (KICS)
Research Article August 5 2025
Modification of Belantamab Mafodotin Dosing to Balance Efficacy and Tolerability in the DREAMM-7 and DREAMM-8 Trials
Research Article August 5 2025
Safety and Efficacy of Daratumumab in Immune Thrombocytopenia
Letter August 5 2025
Prognostic Impact of the PredicT-ALL Classifier in the AALL0434 Trial: A Model Combining NGS, MRD and WBC at Diagnosis
Letter August 4 2025
Addition of romiplostim to immunosuppressive therapy as first-line treatment for patients with aplastic anemia
Research Article August 4 2025
Discovery of molecularly-informed therapeutic strategies for mature T-cell leukemias and lymphomas
Research Article August 4 2025
Brentuximab Vedotin addition to Gemcitabine in Relapsed or Refractory Peripheral T-cell Lymphoma: a LYSA Phase II Study
Research Article August 4 2025
Outcomes of Patients with Suspected Heparin-Induced Thrombocytopenia in a Contemporary Multicenter Cohort
Letter August 4 2025
Ethical Considerations for Hematologic Precursor Conditions
Research Article August 4 2025
Monitoring ctDNA in Aggressive B-cell Lymphoma: A Prospective Correlative Study of ctDNA Kinetics and PET-CT Metrics
Research Article July 30 2025
Immunoglobulin use, survival, and infection outcomes in patients with chronic lymphocytic leukemia
Research Article July 30 2025
Single cell proteomics characterization of bone marrow hematopoiesis with distinct Ras pathway lesions
Research Article July 30 2025
Real-World Outcomes of Infections Following Tisagenlecleucel in Patients with B-Cell ALL: A CIBMTR Analysis
Research Article July 30 2025
Pilot study of an inpatient physical activity intervention for older adults treated intensively for acute myeloid leukemia.
Research Article July 30 2025
Ixazomib decreases the risk of chronic graft-versus-host disease: identification of cGvHD biomarkers.
Letter July 30 2025
ASH Sickle Cell Disease CPKD Guidelines Report
Research Article July 28 2025
Cost-Effectiveness of Upfront vs. Delayed Allogeneic Hematopoietic Stem Cell Transplant for Intermediate Risk AML
Research Article July 28 2025
Targeting S100A9-mediated inflammation: A novel therapeutic approach for CLL
Research Article July 28 2025
Somatic Mutations in STAG2 Are Associated with Separated Megakaryocyte Nuclear Lobes in Myelodysplastic Syndromes
Research Article July 28 2025
A multicenter phase 1/2 trial of lenalidomide and dose-adjusted EPOCH-R in MYC-associated DLBCL
Research Article July 24 2025
A Disrupted Adenosinergic Axis Facilitates Platelet Activation in APS: Exploring a Novel Therapeutic Target
Research Article July 24 2025
Post-transfusion recovery, quality and metabolism of short and long-term stored platelets during controlled inflammation
Research Article July 24 2025
Real-world outcomes of brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma: a CIBMTR analysis
Research Article July 24 2025
Measurable Residual Disease Detection after CAR-T May Predict Response in Patients with Large B-cell Lymphoma
Research Article July 24 2025
HLA-E[pHLA-G] Complex Specific Monoclonal Antibody Enhancing NK Activity in Multiple Myeloma
Research Article July 24 2025
Nivolumab in Combination with R-CHOP for Treatment-Naïve Diffuse Large B-Cell Lymphoma: An Evaluation of Safety and Efficacy
Letter July 24 2025
The IL7 receptor and the RAG complex are required for the onset of B-cell acute lymphoblastic leukemia
Research Article July 24 2025
Long-term results from the AGILE study of azacitidine plus ivosidenib vs placebo in newly diagnosed IDH1-mutated AML
Research Article July 21 2025
A Simple and Efficient Method for the Robust Expansion of Human ILC2s to Prevent Acute GvHD
Review Article July 21 2025
Advances and updates in pediatric anaplastic large cell lymphoma
Review Article July 21 2025
IVIG prophylaxis should be initiated following bispecific antibody therapy in multiple myeloma regardless of IgG levels
Letter July 21 2025
Survival after anti-CD19 CAR T-cell therapy for B-cell non-Hodgkin lymphoma and CLL with 10 years of follow-up
Research Article July 21 2025
YX0798 Is a Highly Potent, Selective, and Orally Effective CDK9 Inhibitor for Treating Aggressive Lymphoma
Research Article July 21 2025
Characterization and prediction of hematotoxicity in pediatric patients receiving tisagenlecuecel
Research Article July 17 2025
Interferon gamma rebalances immunopathological signatures in Chronic Granulomatous Disease through metabolic rewiring
Research Article July 17 2025
Dual targeting of G9a and DNMTs induces anti-tumour effects in multiple myeloma
Letter July 17 2025
Long term follow-up of patients with AL amyloidosis treated on a phase 1 trial of CAEL-101
Review Article July 17 2025
Molecular and Immunological Determinants of Long-Term Survival in Multiple Myeloma
Research Article July 17 2025
In vivo CRISPR screening reveals cooperation of KMT2D and TP53 deficiencies in B-cell lymphomagenesis
Research Article July 17 2025
High-grade B-cell lymphoma, not otherwise specified: an LLMPP study.
Letter July 17 2025
The Efficacy of Teclistamab in Multiple Myeloma Patients with Secondary Plasma Cell Leukemia
Research Article July 17 2025
Novel Devimistat Results in Complete Remissions in Heavily Pre-Treated Burkitt Lymphoma in a phase II trial
Research Article July 17 2025
Ibrutinib plus rituximab versus ibrutinib monotherapy in patients with Waldenström macroglobulinemia: A pooled analysis
Research Article July 17 2025
Utility of IDH1/2 mutations as biomarkers for detection of measurable residual disease in acute myeloid leukemia
Research Article July 17 2025
Long-term follow-up of venetoclax monotherapy in previously treated patients with Waldenström macroglobulinemia
Letter July 17 2025
Can baseline Cytomegalovirus IgG titers predict Cytomegalovirus reactivation after ide-cel therapy?
Research Article July 16 2025
Antibiotic treatment limits survival of peripheral and bone marrow B cell populations
Page 1 of 4

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals